(Q67903737)
Statements
Tetracosactrin vs. methylprednisolone in the prevention of emesis in patients receiving FEC regimen for breast cancer (English)
J Bonneterre
P Kerbrat
P Fargeot
R Metz
H Roche
P Bastit
A Chevrier
M Tubiana-Hulin
G Geyer
1 January 1991